Company
Zyla Life Sciences (0001586105)
Standardized SEC financial data for Zyla Life Sciences — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001586105 · Pharmaceutical Preparations.
Operating margin
-44.8%
Net margin
-58.6%
Revenue growth (YoY)
162.0%
Return on equity
-110.0%
ROIC
-19.8%
Free cash flow
-$11.0M
Debt / equity
2.65×
Current ratio
0.68×
Ratios for fiscal year 2019, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Revenue | $17.0M | $26.1M | $30.4M | $79.5M |
| R&D expense | $33.8M | $14.7M | $3.5M | $22K |
Balance sheet
| USD | FY2018 | FY2018 | FY2019 | FY2019 | FY2019 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $35.7M | — | $36.8M | $17.0M | $12.4M |
| Inventory |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Operating cash flow | -$72.9M | -$65.2M | -$54.8M | -$11.0M |
| Capital expenditures | $7.2M | $88K | $9K | $40K |
Get 0001586105 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001586105/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001586105/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"